Cyclophosphamide (CY)
Cyclophosphamide (CY) is a pharmaceutical drug with 18 clinical trials. Currently 2 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
16
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
2
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Clinical Trials (18)
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT
BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT
G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT
IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT
Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT
Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT
Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT
BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT
Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT
BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18